Trupanion (NASDAQ:TRUP) had its target price increased by Stifel Nicolaus from $33.00 to $43.00 in a research report released on Thursday morning, BenzingaRatingsTable reports. The brokerage currently has a hold rating on the financial services provider’s stock.
A number of other equities analysts have also weighed in on TRUP. Royal Bank of Canada restated a buy rating and set a $40.00 target price on shares of Trupanion in a research report on Monday, June 15th. Zacks Investment Research lowered Trupanion from a hold rating to a sell rating in a research report on Thursday, July 23rd. Lake Street Capital reiterated a buy rating and issued a $50.00 target price on shares of Trupanion in a research report on Friday, May 1st. BidaskClub raised Trupanion from a buy rating to a strong-buy rating in a research note on Thursday, June 18th. Finally, Northland Securities initiated coverage on Trupanion in a report on Thursday, June 25th. They set a buy rating and a $42.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Trupanion presently has a consensus rating of Buy and an average price target of $40.25.
Shares of Trupanion stock opened at $50.57 on Thursday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.69 and a current ratio of 1.69. The company has a fifty day moving average of $44.23 and a 200 day moving average of $33.90. The company has a market capitalization of $1.78 billion, a P/E ratio of -1,011.40 and a beta of 1.56. Trupanion has a fifty-two week low of $20.84 and a fifty-two week high of $53.57.
Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, April 30th. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. Trupanion had a negative return on equity of 1.23% and a negative net margin of 0.40%. The firm had revenue of $111.30 million during the quarter, compared to analysts’ expectations of $110.10 million. During the same quarter last year, the business posted ($0.04) earnings per share. The firm’s revenue was up 28.0% on a year-over-year basis. Analysts forecast that Trupanion will post -0.04 EPS for the current year.
In other news, insider Asher Bearman sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $30.37, for a total transaction of $60,740.00. Following the transaction, the insider now owns 10,422 shares of the company’s stock, valued at $316,516.14. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $50.91, for a total value of $203,640.00. The disclosure for this sale can be found here. Insiders sold a total of 75,900 shares of company stock valued at $3,124,280 in the last 90 days. Company insiders own 13.61% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. purchased a new stake in shares of Trupanion during the first quarter valued at $26,000. Nvwm LLC purchased a new stake in Trupanion in the 1st quarter valued at about $27,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Trupanion by 101.2% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,612 shares of the financial services provider’s stock worth $68,000 after acquiring an additional 1,314 shares in the last quarter. Advisor Group Holdings Inc. purchased a new position in shares of Trupanion during the first quarter worth approximately $81,000. Finally, Atlas Capital Advisors LLC increased its position in shares of Trupanion by 360.0% during the second quarter. Atlas Capital Advisors LLC now owns 2,300 shares of the financial services provider’s stock worth $98,000 after acquiring an additional 1,800 shares during the period. Institutional investors and hedge funds own 92.71% of the company’s stock.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.